☆ 4.7 Article

Pancreatic islet remodeling in cotadutide-treated obese mice

LIFE SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Review Endocrinology & Metabolism

Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1

Rola Hammoud et al.

Summary: Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP1) have incretin activity and play important roles in regulating glucose and lipid metabolism beyond the pancreas. They also have effects on weight loss, atherosclerosis, cardiorenal protection, and other physiological processes. Understanding the mechanisms of GIP and GLP1 action can lead to the development of new treatments for obesity and type 2 diabetes mellitus.

NATURE REVIEWS ENDOCRINOLOGY (2023)

Add to Collection

Letter Surgery

Ghrelin and Its Role as a Marker of Obesity Severity

Reynaldo Martins e Quinino

OBESITY SURGERY (2023)

Add to Collection

Article Endocrinology & Metabolism

Cotadutide effect in liver and adipose tissue in obese mice

Ilitch Aquino Marcondes-de-Castro et al.

Summary: Cotadutide has anti-obesity effects and can improve glucose intolerance and insulin resistance. It also shows beneficial effects on liver lipid metabolism and mitigates steatosis, inflammation, and ER stress. Therefore, Cotadutide could be a potential treatment for type 2 diabetes and associated obesity.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2023)

Add to Collection

Article Cell Biology

ATF5 is a regulator of ER stress and β-cell apoptosis in different mouse models of genetic- and diet-induced obesity and diabetes mellitus

Jinfang Ma et al.

Summary: Endoplasmic reticulum (ER) stress is closely associated with type 2 diabetes (T2D). Activating transcription factor 5 (ATF5) deficiency contributes to increased ER stress and apoptosis in mouse islet micro-organs. Overexpression of ATF5 promotes lipotoxic apoptosis and its downregulation is observed in mouse models of obesity and T2D. Tight control on ATF5 levels is important for the development of novel agents targeting ATF5 for metabolic disease prevention and treatment.

CELLULAR SIGNALLING (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Pancreatic islet cells disarray, apoptosis, and proliferation in obese mice. The role of Semaglutide treatment

Thatiany de Souza Marinho et al.

Summary: Significant injuries to pancreatic islets caused by obesity and insulin resistance can be improved by the GLP-1 receptor agonist Semaglutide. In a study on diet-induced obese mice, it was found that Semaglutide increased islet cell proliferation, recovered islet size and alpha- and beta-cell masses, and improved glucose and hormone levels. These beneficial effects were associated with the reduction of pro-inflammatory markers and the improvement of important pancreatic factors.

BIOCHIMIE (2022)

Add to Collection

Review Immunology

Inflammation in obesity, diabetes, and related disorders

Theresa Rohm et al.

Summary: Obesity can cause chronic systemic inflammation, leading to insulin resistance, beta-cell dysfunction, and ultimately type 2 diabetes. This inflammatory state also contributes to long-term complications of diabetes and may be associated with other conditions like Alzheimer's disease and polycystic ovarian syndrome.

IMMUNITY (2022)

Add to Collection

Article Medicine, Research & Experimental

The current significance and prospects for the use of dual receptor agonism GLP-1/Glucagon

Renata Spezani et al.

Summary: The therapeutic arsenal for treating type 2 diabetes has recently been enriched with the inclusion of GLP-1 receptor agonists, which secondarily reduce appetite, decrease gastric emptying, and reduce body weight. New formulations with fewer adverse effects and extended action periods have improved treatment acceptance and adherence. The pharmaceutical industry's efforts to produce more powerful molecules with fewer side effects will soon lead to the introduction of new drugs for the treatment of type 2 diabetes.

LIFE SCIENCES (2022)

Add to Collection

Article Pharmacology & Pharmacy

Population Pharmacokinetics of Cotadutide in Subjects with Type 2 Diabetes

Ye Guan et al.

Summary: Population pharmacokinetics of cotadutide were characterized in subjects with type 2 diabetes, with body weight, albumin levels, and liver function markers influencing drug clearance, although these effects were not considered clinically significant. Other baseline covariates did not significantly affect cotadutide pharmacokinetics.

CLINICAL PHARMACOKINETICS (2022)

Add to Collection

Article Endocrinology & Metabolism

XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice

Kailun Lee et al.

Summary: This study reveals the crucial role of XBP1 in maintaining beta cell identity, repressing beta-to-alpha cell transdifferentiation, and contributing to beta cell compensation and prevention of diabetes in insulin resistance states.

DIABETOLOGIA (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Endoplasmic Reticulum (ER) Stress and Its Role in Pancreatic β-Cell Dysfunction and Senescence in Type 2 Diabetes

Ji-Hye Lee et al.

Summary: Increased life span and nutritional affluency have resulted in a rise in age-related diseases, such as obesity and type 2 diabetes, which impose significant burdens on society. Dysfunction of pancreatic beta-cells, responsible for glucose control, plays a crucial role in both type 1 and type 2 diabetes. Recent studies have linked cellular senescence to cellular stresses, including ER stress, and have shown that beta-cell senescence contributes to dysfunction and impaired glucose homeostasis. This review discusses the current understanding of cellular senescence, beta-cell function, ER stress, and its impact on beta-cell senescence and dysfunction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Multidisciplinary Sciences

Adaptation to chronic ER stress enforces pancreatic β-cell plasticity

Chien-Wen Chen et al.

Summary: Pancreatic beta-cells are susceptible to ER stress, and chronic stress can lead to the loss of beta-cell function, contributing to the development of diabetes.

NATURE COMMUNICATIONS (2022)

Add to Collection

Review Endocrinology & Metabolism

Endoplasmic Reticulum Stress and Dysregulated Autophagy in Human Pancreatic Beta Cells

Seoil Moon et al.

Summary: The study highlights the importance of pancreatic beta cell homeostasis in diabetes, with a focus on the unfolded protein response and autophagy. By relieving ER stress and regulating autophagic activity, it is possible to protect beta cell function and mass.

DIABETES & METABOLISM JOURNAL (2022)

Add to Collection

Article Anatomy & Morphology

Mice as an Animal Model for the Study of Adipose Tissue and Obesity

Carlos Alberto Mandarim-de-Lacerda et al.

INTERNATIONAL JOURNAL OF MORPHOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

The relationship between different C-peptide level and insulin dose of insulin pump

Yihan Wei et al.

Summary: This study investigated the insulin requirement profiles of T2DM patients with different C-peptide levels on insulin pump therapy. It found differences in basal premeal dose ratio between groups, as well as correlations between C-2h/C-0 and waist circumference, HbA1c, FPG, and 2hPG. BMI and FPG were identified as independent factors influencing %TBa and C-2h/C-0.

NUTRITION & DIABETES (2021)

Add to Collection

Article Endocrinology & Metabolism

Cell Cycle Regulation of the Pdx1 Transcription Factor in Developing Pancreas and Insulin-Producing β-Cells

Xiaodong Zhu et al.

Summary: The research shows that Pdx1 protein exhibits high dynamicity in the cell cycle, with its localization and levels tightly regulated. The cell cycle-dependent regulation of Pdx1 is crucial for completing mitosis. This dynamic regulation has important implications for understanding the dual role of Pdx1 in beta-cell function and proliferation.

DIABETES (2021)

Add to Collection

Article Medicine, General & Internal

Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial

Melanie Davies et al.

Summary: In this study, once-weekly subcutaneous semaglutide 2.4 mg was shown to achieve a significantly greater and clinically meaningful weight reduction compared to placebo in adults with overweight or obesity and type 2 diabetes. Adverse events, particularly gastrointestinal events, were more common with semaglutide compared to placebo.

LANCET (2021)

Add to Collection

Article Endocrinology & Metabolism

Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon-like peptide-1 and glucagon receptor dual agonist, in phase 1 and 2 trials in overweight or obese participants of Asian descent with or without type 2 diabetes

Michiko Asano et al.

Summary: The study demonstrated that cotadutide significantly reduced glucose AUC(0-4h) and body weight in Japanese patients with T2D, with mild gastrointestinal symptoms as the main adverse events and good overall tolerability.

DIABETES OBESITY & METABOLISM (2021)

Add to Collection

Review Endocrinology & Metabolism

Novel therapies with precision mechanisms for type 2 diabetes mellitus

Leigh Perreault et al.

Summary: The article discusses the development of new drugs for type 2 diabetes mellitus (T2DM) and emphasizes their mechanisms of action and potential for treating T2DM. The number of clinical trials is increasing, providing more personalized and safe treatment options for T2DM patients.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

Rajaa Nahra et al.

Summary: Cotadutide treatment for 54 weeks improved glycemic control and weight loss in participants with overweight/obesity and type 2 diabetes. Ad hoc analyses demonstrated improvements in hepatic parameters and support further evaluation of cotadutide in NASH.

DIABETES CARE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity

Mathies M. Jepsen et al.

Summary: Obesity is a serious public health threat, with over 1.1 billion individuals projected to have obesity in 2030 if current trends continue. There is a strong interest in developing obesity treatments based on GLP-1 agonism, with many novel compounds in clinical development aiming to target the GLP-1 receptor or other hormonal systems involved in energy balance and metabolism. Semaglutide is the most advanced compound in clinical development and may become a benchmark for novel anti-obesity compounds utilizing GLP-1 receptor agonism.

EXPERT OPINION ON EMERGING DRUGS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

NEUROD1 Is Required for the Early α and β Endocrine Differentiation in the Pancreas

Romana Bohuslavova et al.

Summary: The research shows that NEUROD1 plays a crucial role in mouse pancreas development, and its deletion affects the expression of key transcription factors, cell proliferation, insulin production, and formation of islets of Langerhans, resulting in severe diabetes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Endocrinology & Metabolism

Targeting β-cell dedifferentiation and transdifferentiation: opportunities and challenges

Wenrui Wang et al.

Summary: The review focuses on the pathological characteristics of diabetes mellitus induced by various stressors or immune-mediated injuries, with a particular emphasis on the reduction of pancreatic islet beta-cell populations and activity. Current treatment strategies are ineffective in slowing disease progression, prompting ongoing research in genetically engineering beta-cell mimetics through bi-directional plasticity. The consensus points to beta-cell dedifferentiation as the primary cause of decreased beta-cell mass and activity, suggesting a potential therapeutic window for intervention. Additionally, exploring strategies for beta-cell regeneration using genetic programming, small molecules, cytokines, and bioengineering is discussed, along with the need for further studies to develop efficient reprogramming methods to generate fully functional beta-cells. Further investigations are deemed necessary to transform diabetes into a potentially curable disease.

ENDOCRINE CONNECTIONS (2021)

Add to Collection

Article Endocrinology & Metabolism

Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans

Simon Veedfald et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Add to Collection

Article Gastroenterology & Hepatology

Alterations in pancreatic islet cell function in response to small bowel resection

Cathleen M. Courtney et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)

Add to Collection

Review Pharmacology & Pharmacy

The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's Disease

Spencer Servizi et al.

CURRENT PHARMACEUTICAL DESIGN (2020)

Add to Collection

Article Biochemical Research Methods

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice

Taewook Kang et al.

MOLECULAR & CELLULAR PROTEOMICS (2020)

Add to Collection

Article Physiology

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

Nathalie Percie du Sert et al.

EXPERIMENTAL PHYSIOLOGY (2020)

Add to Collection

Review Genetics & Heredity

mRNAs, proteins and the emerging principles of gene expression control

Christopher Buccitelli et al.

NATURE REVIEWS GENETICS (2020)

Add to Collection

Review Developmental Biology

β-Cell specific transcription factors in the context of diabetes mellitus and β-cell regeneration

Sivasangari Balakrishnan et al.

MECHANISMS OF DEVELOPMENT (2020)

Add to Collection

Article Multidisciplinary Sciences

Tracing the cellular basis of islet specification in mouse pancreas

Magdalena K. Sznurkowska et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Endocrinology & Metabolism

?A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes?

Deepali Gupta et al.

MOLECULAR METABOLISM (2020)

Add to Collection

Review Cell & Tissue Engineering

NKX6.1 transcription factor: a crucial regulator of pancreatic β cell development, identity, and proliferation

Idil I. Aigha et al.

STEM CELL RESEARCH & THERAPY (2020)

Add to Collection

Review Endocrinology & Metabolism

Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes

Abu Saleh Md Moin et al.

CURRENT DIABETES REPORTS (2019)

Add to Collection

Review Biochemistry & Molecular Biology

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review

David S. Mathiesen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Review Endocrinology & Metabolism

The effects of incretin-based therapies on β-cell function and insulin resistance in type 2 diabetes: A systematic review and network meta-analysis combining 360 trials

Shanshan Wu et al.

DIABETES OBESITY & METABOLISM (2019)

Add to Collection

Article Anatomy & Morphology

Pancreatic Islet Stereology: Estimation of Beta Cells Mass

Thatiany de Souza Marinho et al.

INTERNATIONAL JOURNAL OF MORPHOLOGY (2019)

Add to Collection

Review Endocrinology & Metabolism

Diabetes and lipid metabolism

Vasilios G. Athyros et al.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2018)

Add to Collection

Article Endocrinology & Metabolism

Glucagon-Like Peptide 1 Increases β-Cell Regeneration by Promoting α- to β-Cell Transdifferentiation

Young-Sun Lee et al.

DIABETES (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction

Arunkumar E. Achari et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Add to Collection

Review Cell & Tissue Engineering

PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration

Yaxi Zhu et al.

STEM CELL RESEARCH & THERAPY (2017)

Add to Collection

Article Endocrinology & Metabolism

Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates

S. J. Henderson et al.

DIABETES OBESITY & METABOLISM (2016)

Add to Collection

Article Multidisciplinary Sciences

Effects of Excess Energy Intake on Glucose and Lipid Metabolism in C57BL/6 Mice

Jing Pang et al.

PLOS ONE (2016)

Add to Collection

Review Endocrinology & Metabolism

Role of transcription factors in the transdifferentiation of pancreatic islet cells

Talitha van der Meulen et al.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)

Add to Collection

Review Biochemical Research Methods

Western blotting revisited: Critical perusal of underappreciated technical issues

Thomas A. Gorr et al.

PROTEOMICS CLINICAL APPLICATIONS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Reprogramming of human pancreatic exocrine cells to β-like cells

M. Lemper et al.

CELL DEATH AND DIFFERENTIATION (2015)

Add to Collection

Article Cell Biology

Pharmacological induction of pancreatic islet cell transdifferentiation: relevance to type I diabetes

R. Piran et al.

CELL DEATH & DISEASE (2014)

Add to Collection

Article Biochemical Research Methods

A New Method for Quantitative Real-Time Polymerase Chain Reaction Data Analysis

Xiayu Rao et al.

JOURNAL OF COMPUTATIONAL BIOLOGY (2013)

Add to Collection

Article Multidisciplinary Sciences

GIP-Overexpressing Mice Demonstrate Reduced Diet-Induced Obesity and Steatosis, and Improved Glucose Homeostasis

Su-Jin Kim et al.

PLOS ONE (2012)

Add to Collection

Review Endocrinology & Metabolism

Glucose transporters in the 21st Century

Bernard Thorens et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)

Add to Collection

Article Nutrition & Dietetics

A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet

Julio C. Fraulob et al.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2010)

Add to Collection

Editorial Material Gastroenterology & Hepatology

The Incretins and β-Cell Health: Contrasting Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 as a Path to Understand Islet Function in Diabetes

Lene Jessen et al.

GASTROENTEROLOGY (2009)

Add to Collection

Article Biochemical Research Methods

A protocol for islet isolation from mouse pancreas

Dong-Sheng Li et al.

NATURE PROTOCOLS (2009)

Add to Collection

Review Gastroenterology & Hepatology

Biology of incretins: GLP-1 and GIP

Laurie L. Baggio et al.

GASTROENTEROLOGY (2007)

Add to Collection

Article Endocrinology & Metabolism

Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes

MA Nauck et al.

DIABETES (2004)

Add to Collection

Article Multidisciplinary Sciences

Stereological tools in biomedical research

CA Mandarim-De-Lacerda

ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2003)

Add to Collection

Article Multidisciplinary Sciences

neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas

G Gradwohl et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.